Article Contents
- 2023 (Vol.86)
- 2022 (Vol.85)
- 2021 (Vol.84)
- 2020 (Vol.83)
- 2019 (Vol.82)
- 2018 (Vol.81)
- 2017 (Vol.80)
- 2016 (Vol.79)
- 2015 (Vol.78)
- 2014 (Vol.76)
- 2013 (Vol.74)
- 2012 (Vol.72)
- 2011 (Vol.70)
- 2010 (Vol.68)
- 2009 (Vol.66)
- 2008 (Vol.64)
- 2007 (Vol.62)
- 2006 (Vol.60)
- 2005 (Vol.58)
- 2004 (Vol.56)
- 2003 (Vol.54)
- 2002 (Vol.52)
Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Concern to Bedaquiline: Authors’ Reply
Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2022, v.85 no.1, pp.98-99
https://doi.org/10.4046/trd.2021.0135
Jeongha Mok, M.D., Ph.D. (Pusan National University School of Medicine)
Yewon Kang, M.D. (Pusan National University School of Medicine, Busan)
Yewon Kang, M.D. (Pusan National University School of Medicine, Busan)
Jeongha,
M.
M.
P.
, &
Yewon,
K.
M.
(2022). Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Concern to Bedaquiline: Authors’ Reply. Tuberculosis & Respiratory Diseases, 85(1), 98-99, https://doi.org/10.4046/trd.2021.0135
- Downloaded
- Viewed
Abstract
.
- keywords
- .
- Downloaded
- Viewed
- 0KCI Citations
- 0WOS Citations